E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/27/2012 in the Prospect News Emerging Markets Daily.

Fitch gives YM Drugs D(ind)

Fitch Ratings said it assigned YM Drugs & Chemicals Pvt. Ltd. a national long-term rating of Fitch D(ind).

The agency said that the ratings reflect the numerous letters of credit devolvement, the continuous delays in the repayment of its outstanding term loans' installments and interest, and the overutilization of its cash credit limits in the 12-month period to December from a lack of sufficient liquidity.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.